Trial No.: ARMO AM0010-301 ARTIST 1
A Randomized Phase 3 Study of AM0010 in Combination with FOLFOX Compared with FOLFOX Alone as Second-Line Therapy in Patients with Metastatic Pancreatic Cancer that Have Progressed During or Following a First-Line Gemcitabine Containing Regimen
©2019 Fort Wayne Medical Oncology and Hematology. All Rights Reserved.